Paper21317876
IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
Itakura E and 5 others. Mod Pathol, 2011. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Papers, record 21317876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21317876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-10 | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Biomarkers, Tumor | |
| Disease Progression | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Lymphocytes, Tumor-Infiltrating | |
| Neoplasm Invasiveness | |
| Nevus, Pigmented | |
| RNA, Messenger |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA029605 | NCI NIH HHS | United States | P01CA029605 | PubMed and NIH |
| P01 CA 29605 | NCI NIH HHS | United States | P01CA029605 | PubMed and NIH |
Source NIH RePORTER
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7981073 | Expression of interleukin 10 in human melanoma. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7981073 | PubMed |
| 2 | 18643844 | Immune modulation by melanoma-derived factors. | Exp Dermatol | 2008 | https://conductscience.org/library/papers/18643844 | PubMed |
| 3 | 15671534 | Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15671534 | PubMed |
| 4 | 9646029 | Detection of tyrosinase mRNA in formalin-fixed, paraffin-embedded archival sections of melanoma, using the reverse transcriptase in situ polymerase chain reaction. | Diagn Mol Pathol | 1998 | https://conductscience.org/library/papers/9646029 | PubMed |
| 5 | 17545514 | Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17545514 | PubMed |
| 6 | 18204435 | RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi. | Mod Pathol | 2008 | https://conductscience.org/library/papers/18204435 | PubMed |
| 7 | 17565341 | Mechanisms of local immunosuppression in cutaneous melanoma. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17565341 | PubMed |
| 8 | 15240741 | Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. | J Immunol | 2004 | https://conductscience.org/library/papers/15240741 | PubMed |
| 9 | 12325512 | RT-PCR-based approaches to generate probes for mRNA detection by in situ hybridization. | Methods Mol Biol | 2002 | https://conductscience.org/library/papers/12325512 | PubMed |
| 10 | 12490959 | Inflammation and cancer. | Nature | 2002 | https://conductscience.org/library/papers/12490959 | PubMed |
| 11 | 10629075 | Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10629075 | PubMed |
| 12 | 16932751 | Tumour-induced immune modulation of sentinel lymph nodes. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16932751 | PubMed |
| 13 | 8647620 | Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. | Int J Cancer | 1996 | https://conductscience.org/library/papers/8647620 | PubMed |
| 14 | 10570177 | Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10570177 | PubMed |
| 15 | 12477722 | Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12477722 | PubMed |
| 16 | 11477657 | Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping. | Genes Chromosomes Cancer | 2001 | https://conductscience.org/library/papers/11477657 | PubMed |
| 17 | 14585195 | Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. | J Interferon Cytokine Res | 2003 | https://conductscience.org/library/papers/14585195 | PubMed |
| 18 | 9605762 | Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. | Cancer Res | 1998 | https://conductscience.org/library/papers/9605762 | PubMed |
| 19 | 12710945 | Detection of multiple melanoma-associated markers in melanoma cell lines by RT in situ PCR. | Exp Mol Pathol | 2003 | https://conductscience.org/library/papers/12710945 | PubMed |
| 20 | 10970683 | Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10970683 | PubMed |
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42375809 | Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42375809 | PubMed |
| 42195213 | Circulating Cytokines in Melanoma Prognosis: Current Evidence and Future Perspectives. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42195213 | PubMed |
| 42075611 | Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075611 | PubMed |
| 41816687 | Bacterial colonized melanoma skin models allow to study host-microbe interactions in situ. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41816687 | PubMed |
| 41745410 | Cytokine Profiling in Cutaneous Melanoma: The Emerging Role of Interleukins in Prognostic Stratification with an Up-to-Date Overview of Published Data. | J Pers Med | 2026 | https://conductscience.org/library/papers/41745410 | PubMed |
| 41744822 | Development of a 3D Skin Model for Studying Melanoma Progression. | Cells | 2026 | https://conductscience.org/library/papers/41744822 | PubMed |
| 41742891 | Tertiary lymphoid structures guided opportunities and challenges for immunotherapy in early gastroesophageal junction cancer and low rectal cancer. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41742891 | PubMed |
| 41719156 | The insider's perspective: The intracellular complosome and immune cell dynamics in cancer. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41719156 | PubMed |
| 41627569 | Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/41627569 | PubMed |
| 41407207 | Modulating tumor mechanics and vascular barriers to enhance chemotherapy efficacy in pancreatic tumors and melanoma. | J Control Release | 2026 | https://conductscience.org/library/papers/41407207 | PubMed |
| 41020868 | Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020868 | PubMed |
| 41019059 | The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019059 | PubMed |
| 40951575 | Immune Boosters and Immunotherapy in Allergic Diseases and in Cancer Management. | Arch Razi Inst | 2025 | https://conductscience.org/library/papers/40951575 | PubMed |
| 40841319 | Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/40841319 | PubMed |
| 40672947 | Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40672947 | PubMed |
| 40620536 | Macrophage respiratory complex III governs immune evasion. | Immunometabolism (Cobham) | 2025 | https://conductscience.org/library/papers/40620536 | PubMed |
| 40301712 | PYGO2 regulates IL10 and plays immunosuppressive role through ESCC progression. | BMC Mol Cell Biol | 2025 | https://conductscience.org/library/papers/40301712 | PubMed |
| 40283387 | Unexpectedly High and Difficult-to-Explain Regenerative Capacity in an 82-Year-Old Patient with Insulin-Requiring Type 2 Diabetes and End-Stage Renal Disease. | J Clin Med | 2025 | https://conductscience.org/library/papers/40283387 | PubMed |
| 40149345 | IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149345 | PubMed |
| 39841829 | Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion. | Sci Adv | 2025 | https://conductscience.org/library/papers/39841829 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21317876
GET https://conductscience.org/api/papers/v1/21317876/references?page=2